New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 11, 2014
06:39 EDTEWEdwards Lifesciences upgraded to Outperform from Market Perform at JMP Securities
JMP Securities upgraded Edwards Lifesciences to Outperform from Market Perform and established a $97 price target. The firm upgraded shares following positive survey results that indicate TAVI volumes will continue to grow 30%+, the approval of Sapien XT will shift market share back to Edwards and growth is coming from larger valve sizes and smaller sheaths.
News For EW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 28, 2015
16:30 EDTEWEdwards Lifesciences sees Q3 EPS 92c-$1.00, consensus 98c
Sees Q3 revenue $580M-$620M, consensus $587.06M.
16:28 EDTEWEdwards Lifesciences raises FY15 EPS view to $4.30-44.40, consensus $4.28
Backs FY15 revenue view $2.3B-$2.5B, consensus $2.41B
16:26 EDTEWEdwards Lifesciences reports Q2 EPS $1.13 , consensus $1.05
Subscribe for More Information
15:21 EDTEWNotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use